Arca Biopharma | ABIO - Frais De Vente Et D'Administration





Frais De Vente Et D'Administration Changement Date
Alterity Therapeutics Limited AUD 1.45M 703.96K 2025-12
Amgen USD 1.72B 134M 2026-06
Arca Biopharma USD 2.23M 1.08M 2025-12
Biogen USD 709.7M 155.4M 2026-06
Brainstorm Cell Therapeutics USD 1.21M 178K 2026-03
Bristol-Myers Squibb USD 1.83B 209M 2026-06
Capricor Therapeutics USD 1.92M 446.47K 2025-12
Cipla INR 13.25B 101.8M 2025-12
Clal Biotechnology ILS 3.31M 513K 2022-12
Compugen USD 2.43M 222K 2026-03
CSL USD 1.23B 498M 2025-12
Cytokinetics USD 104.4M 499K 2026-06
Daiichi Sankyo JPY 249.96B 21.73B 2026-06
Gilead Sciences USD 1.52B 70M 2026-06
GlaxoSmithKline GBP 2.19B 75M 2026-06
Grifols EUR 320.45M 12.65M 2025-12
Laboratory Of America USD 577.2M 26.2M 2026-06
Myriad Genetics USD 122.3M 6.7M 2025-12
Otsuka Holdings JPY 274.44B 14.95B 2026-06
Pfizer USD 3.41B 496M 2026-06
United Therapeutics USD 206.7M 50.1M 2026-06